Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Dimeticone, activated
D.D.D. Limited
A03AX; A03AX13
Dimeticone, activated
21 mg/ 2.5 millilitre(s)
Oral suspension
Product not subject to medical prescription
Other drugs for functional gastrointestinal disorders; silicones
Marketed
1983-10-05
PACKAGE LEAFLET: INFORMATION FOR THE USER DENTINOX INFANT COLIC DROPS 21 MG/2.5 ML ORAL SUSPENSION ACTIVATED DIMETICONE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. - Keep this leaflet. You may need to read it again. - If you notice any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. - If you need more information or advice on the medicine or your baby’s condition, or if the symptoms persist, speak to your health visitor, pharmacist or doctor. IN THIS LEAFLET: 1. What Dentinox Infant Colic Drops are and what they are used for 2. What you need to know before you use Dentinox Infant Colic Drops 3. How to use Dentinox Infant Colic Drops 4. Possible side effects 5. How to store Dentinox Infant Colic Drops 6. Contents of the pack and other information 7. About infant colic 1. WHAT DENTINOX INFANT COLIC DROPS ARE AND WHAT THEY ARE USED FOR Dentinox Infant Colic Drops contain the active ingredient activated dimeticone. This product belongs to a group of medicines called surface active substances. Dentinox Infant Colic Drops works by helping to release trapped wind. This helps to relieve tummy pain and indigestion. Dentinox Infant Colic Drops is for the gentle relief of wind and griping pains in babies. This medicine can be used from birth onwards. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE DENTINOX INFANT COLIC DROPS DO NOT GIVE DENTINOX INFANT COLIC DROPS IF YOUR BABY IS BEING TREATED FOR A THYROID DISORDER; SEEK ADVICE FROM YOUR DOCTOR INSTEAD. DO NOT GIVE DENTINOX INFANT COLIC DROPS IF YOU THINK YOUR BABY MIGHT BE ALLERGIC (hypersensitive) TO DIMETICONE OR ANY OTHER INGREDIENTS OF DENTINOX INFANT COLIC DROPS (listed in section 6 of this leaflet). TAKING OTHER MEDICINES: If your baby is being treated with levothyroxine for a thyroid disorder, using Dentinox Infant Coli Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Dentinox Infant Colic Drops 21 mg/2.5 ml Oral Suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Activated Dimeticone 21.0 mg/2.5 ml. Excipients: also includes sucrose, 0.396 g per 2.5 ml Methylhydroxybenzoate (E218), Ethylhydroxybenzoate (E214) and Propylhydroxybenzoate (E216) For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Oral suspension A colourless to translucent white viscous emulsified suspension with a characteristic odour. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS In the management of infant colic. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION ½ teaspoon (2.5 ml) with or after each feed. May be added to the infant’s bottle or given orally using the spoon provided. Maximum 6 doses per day. 4.3 CONTRAINDICATIONS Hypersensitivity to any of the ingredients. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Shake before use. This product contains parahydroxybenzoates, which may cause allergic reactions (possibly delayed). Keep all medicines out of reach of children. If symptoms persist obtain medical advice. 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION Levothyroxine may bind to simeticone. Absorption of levothyroxine may be impaired if Dentinox Infant Colic Drops are given concurrently to infants treated for thyroid disorders. 4.6 FERTILITY, PREGNANCY AND LACTATION Not applicable. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ __ Read the complete document